Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today’s Biggest Gainers?

Should you buy or sell these 3 major gainers? Lonmin Plc (LON: LMI), Oxford BioMedica plc (LON: OXB) and Bango plc (LON: BGO)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Lonmin (LSE: LMI) have soared by over 5% today after the mining company announced the appointment of a new CFO. Barrie van der Merwe will take over on 17 May and the market seems to have welcomed this prompt decision by the company following the resignation of Simon Scott.

Clearly, this is a time of major change for Lonmin as it seeks to implement an updated strategy in response to exceptionally difficult trading conditions. As part of this, it is restructuring its business and also seeking to cut costs; both of which are likely to have a positive impact on Lonmin’s bottom line over the medium to long term. And with Lonmin having the capital through which to effect its new plan following last year’s fundraising, its future seems to be brighter than it was just a handful of months ago.

This increased confidence plus a more stable commodity price environment has led to a rise in Lonmin’s share price of 99% since the turn of the year. This rapid increase could continue, although Lonmin remains a relatively high risk play and may only be of interest to less risk averse investors.

Also rising today are shares in Oxford BioMedica (LSE: OXB), with them being up over 11% despite no significant news flow having been released by the company today. In fact, the gene therapy specialist has not released an update since 7 March when it announced a new and expanded collaboration with Immune Design Corp. Since then its shares have fallen by around 6% but looking ahead, the company has clear potential to deliver profitability.

The challenge for investors, though, is that profitability may still be a long way off. And in the meantime Oxford BioMedica is in a cash burn phase which could require further fundraisings following its £8.1m placing in February. As such, and while Oxford BioMedica has a bright long term future in a very appealing space, it may only be worth a closer look for less risk averse investors.

Meanwhile, shares in mobile payments company Bango (LSE: BGO) have risen by 12% today despite a lack of news flow. Despite this, its shares have still fallen by 60% since the turn of the year even though Bango’s full-year results have showed that it is making progress. For example, it experienced significant growth in end user spend, with the company also doubling the rate of spending through the Bango payment platform. And with a stable cost base, it seems to be well-positioned to move towards profitability.

Of course, the market seems to be somewhat downbeat on Bango’s prospects judging by its recent share price fall. While today’s upward movement could indicate a change in sentiment, it may be prudent to await confirmation of this over the medium term before piling in.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Where will Rolls-Royce shares go next? Let’s ask the experts

Rolls-Royce shares have wobbled as aviation uncertainty grows. But can the City's glowing forecasts help get the price climbing again?

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

No savings at 45? Here’s how investors could still build a £17,360 second income

It’s never too late to start investing, and with compounding working over time, Andrew Mackie shows how investors could still…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

How to invest £10,000 to aim for a £6,108 annual passive income

UK REITs have been getting a lot of attention. But our author thinks they're still the place to look for…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

What sort of passive income stream could you build for a fiver a day?

Think a few pounds a day might not go far? In fact, that could be the basis of some pleasing…

Read more »

British Isles on nautical map
Investing Articles

I sense a potential opportunity if the FTSE 100 loses this quality growth stock…

Rightmove falling out of the FTSE 100 might have been unthinkable a year ago. But that's the reality investors are…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

The largest S&P 500 holding in my ISA is…

Edward Sheldon's making a large bet on this S&P 500 stock. Because he sees the long-term risk/reward proposition very attractive.

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

Stock market cycles: where are we now and what’s coming next?

What's the stock market saying about the AI-driven demand for memory chips that’s driving share prices higher? Cyclical? Or a…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

How to invest £3 a day in FTSE shares to target a passive income of £5,439 a year

Investing just a few pounds a day in FTSE shares will build over time and could unlock a passive income…

Read more »